MF Brizzi, P Dentelli, R Gambino, S Cabodi, M … - Diabetes, 2002 - Am Diabetes Assoc Advanced glycation end products (AGEs) have been implicated in the accelerated vascular injury
occurring in diabetes. We recently reported that LDL prepared from type 2 diabetic patients
(dm-LDL), but not normal LDL (n-LDL) triggered signal transducers and activators of ... Cited by 18 - Related articles - BL Direct - All 4 versions
- ►nih.gov MF Brizzi, P Dentelli, M Pavan, A Rosso, R … - Journal of Clinical …, 2002 - Am Soc Clin Investig Modified LDL is a major cause of injury to the endothelium in diabetes. In the present study, we
analyzed the effects on endothelial cells of LDL recovered from type 2 diabetic patients
(dm-LDL) or from nondiabetic subjects (n-LDL). Treatment of human umbilical vein ... Cited by 14 - Related articles - BL Direct - All 7 versions
E Santini, R Lupi, S Baldi, S Madec, D Chimenti, E … - Diabetologia, 2008 - Springer Abstract Aims/hypothesis Inflammation is a mechanism of glomeru- lar damage in chronic
glomerulopathies. LDL may increase the production of inflammatory cytokines in renal
tissues. However, the relative role of native, oxidised and glycated LDL in promoting this ... Cited by 4 - Related articles - All 3 versions
M Melia, C Periera, C Ferronb, F Parssegnyc, C … - Journal of Alzheimer's …, 2002 - IOS Press Abstract: Pentosidine, an advanced glycation end product (AGE), was assayed by HPLC in serum
proteins from patients with Alzheimer type dementia (AD), patients with diabetes mellitus (D),
and healthy (C) age-matched old subjects (mean age from each group = 84 years). ... Cited by 6 - Related articles - BL Direct - All 3 versions
[CITATION] Impact of in vivo LDL glycation on platelet aggregation and monocyte chemotaxis …
T Fleming, N Rabbani, PJ … - Annals of the New York …, 2008 - pubmedcentral.nih.gov An analytical procedure was developed for nucleotide advanced glycation endproducts formed
by the reaction of glyoxal and methylglyoxal with deoxyguanosine under physiological
conditions. For this, the imidazopurinone derivatives, 3-(2′-deoxyribosyl)-6,7-dihydro-6,7 ... Cited by 2 - Related articles - BL Direct - All 8 versions
O Brouwers, T Teerlink, J van Bezu, R … - ANNALS-NEW …, 2008 - interscience.wiley.com Increased formation of the reactive dicarbonyl compound methylglyoxal (MGO) and MGO-derived
advanced glycation end products (AGEs) seems to be implicated in endothelial dysfunction and
the development of diabetic vascular complications. MGO reacts with arginine residues in ... Cited by 2 - Related articles - BL Direct - All 5 versions
N Selvaraj, Z Bobby, MG Sridhar - Archives of medical research, 2008 - ncbi.nlm.nih.gov Among the various mechanisms proposed, the process of non-enzymatic glycation of proteins
is believed to play an important role in the pathogenesis of chronic complications associated
with renal failure. The two traditional factors found to modulate the early glycation of ... Cited by 2 - Related articles
[CITATION] Veiga-da-Cunha M, Vertommen D, Buysschaert M, and Van Schaftingen E
N Bhattacharyya, A Pal, S Patra, AK Haldar, S Roy, … - International …, 2008 - Elsevier Methylglyoxal is a normal metabolite and has the potential to affect a wide variety of cellular
processes. In particular, it can act selectively against malignant cells. The study described herein
was to investigate whether methylglyoxal can enhance the non-specific immunity of the ... Cited by 2 - Related articles - All 2 versions
